Confluence Wealth Management’s Edwards Lifesciences EW Stock Holding History

Confluence Wealth Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.17M	Sell	5,323 -12,468	-70%	-$973K	0.57%	42
2020 Q2	$1.23M	Buy	17,791 +703	+4%	+$50K	0.58%	46
2020 Q1	$1.07M	Buy	17,088 +1,305	+8%	+$94.1K	0.6%	46
2019 Q4	$1.23M	Sell	15,783 -186	-1%	-$14.5K	0.57%	42
2019 Q3	$1.17M	Buy	15,969 +153	+1%	+$10.7K	0.57%	42
2019 Q2	$974K	Hold	15,816	–	–	0.48%	49
2019 Q1	$1.01M	Buy	15,816 +129	+0.8%	+$7.36K	0.5%	47
2018 Q4	$801K	Sell	15,687 -408	-3%	-$20.6K	0.45%	58
2018 Q3	$934K	Sell	16,095 -234	-1%	-$11.4K	0.48%	54
2018 Q2	$792K	Buy	16,329 +219	+1%	+$10.2K	0.42%	59
2018 Q1	$749K	Buy	16,110 +6,897	+75%	+$300K	0.38%	59
2017 Q4	$346K	Buy	+9,213	New	+$338K	0.16%	98

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Confluence Wealth Management's EW Position: Q3 2020 in Review

Confluence Wealth Management reduced its Edwards Lifesciences (EW) stake by 70% in Q3 2020, selling an estimated $973K and leaving 5,323 shares worth $1.17M. The position accounts for 0.57% of the portfolio, ranked #42.

Confluence Wealth Management first reported a position in EW in Q4 2017 and has held it in 12 quarters since. The position peaked at $1.23M in Q2 2020. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

Confluence Wealth Management held 5,323 shares of Edwards Lifesciences worth $1.17M as of Q3 2020.
Confluence Wealth Management sold 12,468 Edwards Lifesciences shares in Q3 2020, an estimated $973K.
Edwards Lifesciences made up 0.57% of Confluence Wealth Management's portfolio in Q3 2020, its #42 holding.
Confluence Wealth Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 12 quarters since.
Confluence Wealth Management's Edwards Lifesciences position peaked at $1.23M in Q2 2020.
1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.